Market Overview

UPDATE: Deutsche Bank Upgrades Mednax to Hold, Raises PT

Related MD
MedData Launches iPhone App To Improve Billing Reconciliation For Surgical Practices
US Stock Futures Surge Ahead Of Federal Budget

In a report published Friday, Deutsche Bank upgraded its rating on Mednax (NYSE: MD) from Sell to Hold, and raised its price target from $65.00 to $76.00.

Deutsche Bank noted, “MD's last two quarters have significantly allayed our concerns about a steeper slow-down in NICU trends. The combination of better-than-expected NICU volumes and stronger margins force us to reconsider our more cautious view on MD's earnings power. We move to Hold (from Sell), and raise our PT to $76 ($65) on higher estimates and our year-end process to roll-forward valuations off the new out-year (2014).”

Mednax closed on Thursday at $73.41.

Latest Ratings for MD

DateFirmActionFromTo
Oct 2014BairdInitiates Coverage onOutperform
Sep 2014SunTrust Robinson HumphreyInitiates Coverage onNeutral
Sep 2014Deutsche BankMaintainsBuy

View More Analyst Ratings for MD
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Upgrades Analyst Ratings

 

Related Articles (MD)

Around the Web, We're Loving...

Get Benzinga's Newsletters